Zobrazeno 1 - 10
of 30
pro vyhledávání: '"S. A. P. Chubb"'
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Background Older general population-based studies found an inverse association between serum HDL-cholesterol and both cardiovascular disease (CVD) events and mortality, but more recent data have suggested a U-shaped relationship. Whether thi
Externí odkaz:
https://doaj.org/article/e54a634bdea4411fa3425f194d7e9159
Autor:
Judith S Brand, Maroeska M Rovers, Bu B Yeap, Harald J Schneider, Tomi-Pekka Tuomainen, Robin Haring, Giovanni Corona, Altan Onat, Marcello Maggio, Claude Bouchard, Peter C Y Tong, Richard Y T Chen, Masahiro Akishita, Jourik A Gietema, Marie-Hélène Gannagé-Yared, Anna-Lena Undén, Aarno Hautanen, Nicolai P Goncharov, Philip Kumanov, S A Paul Chubb, Osvaldo P Almeida, Hans-Ulrich Wittchen, Jens Klotsche, Henri Wallaschofski, Henry Völzke, Jussi Kauhanen, Jukka T Salonen, Luigi Ferrucci, Yvonne T van der Schouw
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e100409 (2014)
BACKGROUND:Low total testosterone (TT) and sex hormone-binding globulin (SHBG) concentrations have been associated with the metabolic syndrome (MetS) in men, but the reported strength of association varies considerably. OBJECTIVES:We aimed to investi
Externí odkaz:
https://doaj.org/article/58bf1d1e8e2c4151a872236b0e95914f
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74355 (2013)
Low serum magnesium concentrations have been associated with cardiovascular disease risk and outcomes in some general population studies but there are no equivalent studies in diabetes. Metformin may have cardiovascular benefits beyond blood glucose
Externí odkaz:
https://doaj.org/article/70ac3607c80e47b1b9ae833aa1c5ecec
Publikováno v:
Internal Medicine Journal. 48:1215-1221
BACKGROUND Pharmacotherapy and supportive care for diabetes in Australia are improving, with potential beneficial effects on therapeutic procrastination. AIM To determine whether glycaemic thresholds for therapeutic intensification in type 2 diabetes
Autor:
Shaye Griffiths, David G. Bruce, Ashley Makepeace, Struan F.A. Grant, S. A. P. Chubb, Andrew T. Hattersley, Wendy A. Davis, Sian Ellard, Christine Bundell, Timothy M. E. Davis, Kirsten Peters
Publikováno v:
Internal Medicine Journal. 48:803-809
Diabetes is a major global health problem that has been characterised as one of the largest epidemics in history.1 The progressively increasing number of people diagnosed with diabetes means that more resources are required to manage the disease and
Autor:
Yi X. Chan, Ken K. Y. Ho, Helman Alfonso, P. G. Fegan, S. A. P. Chubb, Bu B. Yeap, Graeme J. Hankey, Jonathan Golledge, Leon Flicker
Publikováno v:
Clinical Endocrinology. 88:333-340
Objective: Insulin-like growth factor 1 (IGF1) has anabolic and growth-promoting effects, raising concerns regarding its potential to promote tumour growth. Circulating IGF1 is bound to binding proteins, which modulate bioavailability of IGF1. This s
Autor:
M. Henze, Leon Flicker, Graeme J. Hankey, Helman Alfonso, Paul Norman, Osvaldo P. Almeida, Bu B. Yeap, S. A. P. Chubb, Jonathan Golledge, Jill George
Publikováno v:
Diabetic Medicine. 34:786-793
Aims To investigate behavioural, physical and biochemical characteristics associated with diabetes in the oldest age group of elderly men. Methods We conducted a cross-sectional analysis of community-dwelling men aged 79–97 years from Perth, Wester
Publikováno v:
Clinical endocrinologyREFERENCES. 92(4)
Objective Since the results of published studies assessing thyroid dysfunction complicating diabetes have been variable in quality, inconsistent and may not reflect contemporary clinical care, the aim of this study was to determine its prevalence and
Publikováno v:
Diabetes, Obesity and Metabolism. 18:598-606
To validate the findings, in a usual care setting, of glycaemic intervention trials, which have shown that tight control in patients with recently diagnosed type 2 diabetes protects against death during post-study monitoring, but that it may be delet
Autor:
Richard Eastell, Konstantinos Makris, S. A. P. Chubb, Howard A. Morris, Cyrus Cooper, John A. Kanis, N. R. Jorgesen, Etienne Cavalier, Samuel Vasikaran
Publikováno v:
Morris, H A, Eastell, R, Rye Jørgensen, N, Cavalier, E, Vasikaran, S, Chubb, S A P, Kanis, J A, Cooper, C, Makris, K & IFCC-IOF Working Group for Standardisation of Bone Marker Assays (WG-BMA) 2017, ' Clinical usefulness of bone turnover marker concentrations in osteoporosis ', Clinica Chimica Acta, vol. 467, pp. 34–41 . https://doi.org/10.1016/j.cca.2016.06.036
Current evidence continues to support the potential for bone turnover markers (BTM) to provide clinically useful information particularly for monitoring the efficacy of osteoporosis treatment. Many of the limitations identified earlier remain, princi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca17e67b2b250132c99e389b1f24138
https://portal.findresearcher.sdu.dk/da/publications/753d1fa5-a09f-4ad0-b8b1-b14cb6980ccc
https://portal.findresearcher.sdu.dk/da/publications/753d1fa5-a09f-4ad0-b8b1-b14cb6980ccc